Vanguard Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $162M | Buy |
|
|||||
|
2025
Q1 | $156M | Sell |
|
|||||
|
2024
Q4 | $163M | Buy |
|
|||||
|
2024
Q3 | $139M | Sell |
|
|||||
|
2024
Q2 | $106M | Sell |
|
|||||
|
2024
Q1 | $122M | Sell |
|
|||||
|
2023
Q4 | $119M | Sell |
|
|||||
|
2023
Q3 | $121M | Buy |
|
|||||
|
2023
Q2 | $127M | Buy |
|
|||||
|
2023
Q1 | $115M | Buy |
|
|||||
|
2022
Q4 | $179M | Buy |
|
|||||
|
2022
Q3 | $133M | Buy |
|
|||||
|
2022
Q2 | $145M | Buy |
|
|||||
|
2022
Q1 | $131M | Buy |
|
|||||
|
2021
Q4 | $113M | Sell |
|
|||||
|
2021
Q3 | $119M | Buy |
|
|||||
|
2021
Q2 | $32.8M | Buy |
|
|||||
|
2021
Q1 | $26.8M | Buy |
|
|||||
|
2020
Q4 | $6.08M | Buy |
|